Metformin in the treatment of non-alcoholic fatty liver disease: a meta-analysis

被引：0
|
作者：
De Lusong, Mark Anthony A. [1 ]
Pilapil, J. [1 ]
Limquiaco, J. [1 ]
Feir, S. [1 ]
Prodigalidad, P. [1 ]
Cabanayan, E. [1 ]
Nolasco, E. [1 ]
Banez, V. [1 ]
Zano, F. [1 ]
Daez, L. [1 ]
Gloria, V. [1 ]
Comia, A. [1 ]
Sy, P. [1 ]
Atienza, M. [1 ]
Labio, E. [1 ]
机构：
[1] Philippine Gen Hosp, Gastroenterol Sect, Manila, Philippines
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A35 / A35
页数：1
相关论文
共 50 条
  • [1] Metformin in the treatment of non-alcoholic fatty liver disease: a meta-analysis
    De Lusong, M. A.
    LIVER INTERNATIONAL, 2006, 26 : 102 - 102
  • [2] Metformin in non-alcoholic fatty liver disease: A systematic review and meta-analysis
    Li, Yan
    Liu, Lei
    Wang, Bin
    Wang, Jun
    Chen, Dongfeng
    BIOMEDICAL REPORTS, 2013, 1 (01) : 57 - 64
  • [3] Ezetimibe for the treatment of non-alcoholic fatty liver disease: A meta-analysis
    Nakade, Yukiomi
    Murotani, Kenta
    Inoue, Tadahisa
    Kobayashi, Yuji
    Yamamoto, Takaya
    Ishii, Norimitsu
    Ohashi, Tomohiko
    Ito, Kiyoaki
    Fukuzawa, Yoshitaka
    Yoneda, Masashi
    HEPATOLOGY RESEARCH, 2017, 47 (13) : 1417 - 1428
  • [4] Metformin in the treatment of non-alcoholic fatty liver disease
    De Lusong, M. A.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S192 - S192
  • [5] Effects of saroglitazar in the treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis: A systematic review and meta-analysis
    Bandyopadhyay, Sanjay
    Samajdar, Shambo Samrat
    Das, Saibal
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2023, 47 (07)
  • [6] Effects of Probiotics on Non-Alcoholic Fatty Liver Disease - A Meta-analysis
    Humarang, Jeffrey
    Mappala, Higinio
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 331 - 331
  • [7] Meta-analysis: vitamin D and non-alcoholic fatty liver disease
    Eliades, M.
    Spyrou, E.
    Agrawal, N.
    Lazo, M.
    Brancati, F. L.
    Potter, J. J.
    Koteish, A. A.
    Clark, J. M.
    Guallar, E.
    Hernaez, R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (03) : 246 - 254
  • [8] Sarcopenia and Risk of Non-Alcoholic Fatty Liver Disease: A Meta-Analysis
    Wijarnpreecha, Karn
    Panjawatanan, Panadeekarn
    Thongprayoon, Charat
    Jaruvongvanich, Veeravich
    Ungprasert, Patompong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S507 - S508
  • [9] Non-alcoholic fatty liver disease in children and adolescents: a meta-analysis
    Horlenko, Olesya
    Pushkarenko, Olga
    PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2022, 18 (03): : 219 - 227
  • [10] Paraoxonase 1 and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis
    Kotani, Kazuhiko
    Watanabe, Jun
    Miura, Kouichi
    Gugliucci, Alejandro
    MOLECULES, 2021, 26 (08):
12345